Stryker Stock Performance
| SYK Stock | USD 360.82 7.32 1.99% |
Stryker has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.15, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Stryker's returns are expected to increase less than the market. However, during the bear market, the loss of holding Stryker is expected to be smaller as well. Stryker right now has a risk of 1.36%. Please validate Stryker maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Stryker will be following its existing price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Stryker is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
Actual Historical Performance (%)
One Day Return (0.04) | Five Day Return (2.29) | Year To Date Return 3.58 | Ten Year Return 262.33 | All Time Return 432.7 K |
Forward Dividend Yield 0.0098 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 3.52 | Dividend Date 2026-01-30 |
1 | Insider Trading | 11/28/2025 |
2 | Gear Up for Stryker Q4 Earnings Wall Street Estimates for Key Metrics | 01/26/2026 |
3 | What Stryker s TD Cowen Downgrade on Valuation Grounds Means For Shareholders | 01/27/2026 |
4 | Global Osteotomy Plates Market Projected to Reach USD 698.5 Million by 2035 Joint Preservation Technologies Overtaking Traditional Arthroplasty | 01/28/2026 |
5 | Stryker Q4 results beat on both lines 2026 EPS guidance includes consensus | 01/29/2026 |
| Stryker dividend paid on 30th of January 2026 | 01/30/2026 |
7 | Disposition of 13840 shares by J Pierce of Stryker at 96.64 subject to Rule 16b-3 | 02/02/2026 |
8 | Disposition of 13840 shares by Spencer Stiles of Stryker at 96.64 subject to Rule 16b-3 | 02/03/2026 |
| Begin Period Cash Flow | 3.7 B | |
| Total Cashflows From Investing Activities | -4.9 B |
Stryker Relative Risk vs. Return Landscape
If you would invest 35,515 in Stryker on November 7, 2025 and sell it today you would earn a total of 567.00 from holding Stryker or generate 1.6% return on investment over 90 days. Stryker is generating 0.0354% of daily returns assuming volatility of 1.3621% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Stryker, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Stryker Target Price Odds to finish over Current Price
The tendency of Stryker Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 360.82 | 90 days | 360.82 | about 43.3 |
Based on a normal probability distribution, the odds of Stryker to move above the current price in 90 days from now is about 43.3 (This Stryker probability density function shows the probability of Stryker Stock to fall within a particular range of prices over 90 days) .
Stryker Price Density |
| Price |
Predictive Modules for Stryker
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Stryker. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Stryker's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Stryker Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Stryker is not an exception. The market had few large corrections towards the Stryker's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Stryker, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Stryker within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | 0.15 | |
σ | Overall volatility | 6.82 | |
Ir | Information ratio | -0.06 |
Stryker Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Stryker for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Stryker can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Stryker is unlikely to experience financial distress in the next 2 years | |
| Over 82.0% of the company shares are owned by institutional investors | |
| On 30th of January 2026 Stryker paid $ 0.88 per share dividend to its current shareholders | |
| Latest headline from seekingalpha.com: Amgen Q4 preview MariTide progress to dominate investors focus |
Stryker Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Stryker Stock often depends not only on the future outlook of the current and potential Stryker's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Stryker's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 382.2 M | |
| Cash And Short Term Investments | 4.1 B |
Stryker Fundamentals Growth
Stryker Stock prices reflect investors' perceptions of the future prospects and financial health of Stryker, and Stryker fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stryker Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0793 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 151.54 B | ||||
| Shares Outstanding | 382.42 M | ||||
| Price To Earning | 63.07 X | ||||
| Price To Book | 6.15 X | ||||
| Price To Sales | 5.49 X | ||||
| Revenue | 25.12 B | ||||
| Gross Profit | 16.34 B | ||||
| EBITDA | 5.69 B | ||||
| Net Income | 3.25 B | ||||
| Cash And Equivalents | 3.65 B | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 14.86 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 2.00 X | ||||
| Book Value Per Share | 58.61 X | ||||
| Cash Flow From Operations | 5.04 B | ||||
| Earnings Per Share | 8.41 X | ||||
| Market Capitalization | 137.99 B | ||||
| Total Asset | 47.84 B | ||||
| Retained Earnings | 18.53 B | ||||
| Working Capital | 7.23 B | ||||
| Current Asset | 1.15 B | ||||
| Current Liabilities | 707.5 M | ||||
About Stryker Performance
By examining Stryker's fundamental ratios, stakeholders can obtain critical insights into Stryker's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Stryker is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 200.14 | 143.42 | |
| Return On Tangible Assets | 0.14 | 0.10 | |
| Return On Capital Employed | 0.14 | 0.22 | |
| Return On Assets | 0.07 | 0.11 | |
| Return On Equity | 0.14 | 0.19 |
Things to note about Stryker performance evaluation
Checking the ongoing alerts about Stryker for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Stryker help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Stryker is unlikely to experience financial distress in the next 2 years | |
| Over 82.0% of the company shares are owned by institutional investors | |
| On 30th of January 2026 Stryker paid $ 0.88 per share dividend to its current shareholders | |
| Latest headline from seekingalpha.com: Amgen Q4 preview MariTide progress to dominate investors focus |
- Analyzing Stryker's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stryker's stock is overvalued or undervalued compared to its peers.
- Examining Stryker's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Stryker's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stryker's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Stryker's stock. These opinions can provide insight into Stryker's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Stryker assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.559 | Dividend Share 3.4 | Earnings Share 8.41 | Revenue Per Share | Quarterly Revenue Growth 0.114 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Stryker's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.